Indian equity benchmarks advanced on Thursday, driven by gains in heavyweight financials, although a decline in Tata Motors ...

The sector needs to clean up its act and focus on quality. It won’t until New Delhi insists on more and better regulations.

which could disrupt India's pharma industry, leading to higher prices and reduced market share. He urges the Indian government to consider negotiations or a free trade agreement to avoid this crisis.

Warns that Indian pharmaceutical products could become more expensive in the US, reducing their competitiveness in one of the ...

President Donald Trump announced upcoming tariffs on the pharmaceutical industry, without elaborating on specifics. He also ...

The session highlighted existing policy support mechanisms and upcoming opportunities under the PRIP scheme aimed at ...

The e-commerce sector stands out as an exception, maintaining its competitive pay. Following e-commerce, there are other sectors, including automotive, pharmaceuticals, manufacturing, and financial ...

US President Donald Trump stated that the US relies heavily on pharmaceuticals produced in other countries, particularly ...

U.S. President Trump imposes 25% tariff on auto imports, spotlight on pharma imports, Indian industry at risk.

OA affects about 15-20% of the Indian population, especially the elderly, with women being more vulnerable. It leads to joint ...

His areas of experience include handling complex quality control operations, regulatory compliance, and leadership of large ...